Walvax Biotechnology Co., Ltd. (SHE:300142)
12.36
+0.10 (0.82%)
Feb 3, 2026, 11:55 AM CST
10.75% (1Y)
| Market Cap | 19.61B +4.8% |
| Revenue (ttm) | 2.40B -22.5% |
| Net Income | 49.24M -59.8% |
| EPS | 0.03 -59.8% |
| Shares Out | 1.60B |
| PE Ratio | 398.18 |
| Forward PE | 75.45 |
| Dividend | 0.03 (0.24%) |
| Ex-Dividend Date | Jan 9, 2026 |
| Volume | 23,425,234 |
| Average Volume | 73,561,804 |
| Open | 12.81 |
| Previous Close | 12.26 |
| Day's Range | 12.23 - 12.81 |
| 52-Week Range | 9.70 - 14.65 |
| Beta | 0.49 |
| RSI | 49.59 |
| Earnings Date | Mar 28, 2026 |